Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change and implementation when countries moved from chloroquine to SP, the different constraints of moving to artemisinin-based combination therapy (ACT) in Africa are less well documented. Methods: A narra...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Copyright holder:
- Amin et al.
- Copyright date:
- Citation: Amin, A. A. et al. (2007). 'The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya', Malaria Journal, 6: 72. [This article is available from: http://www.malariajournal.com/content/6/1/72]. Copyright 2007 Amin et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record